The goal of the present study was to develop a fully three-dimensional (3D) coculture system that would allow for systematic evaluation of the interplay between activated macrophages (AMs) and chondrocytes in osteoarthritic disease progression and treatment. Toward this end, our coculture system was first validated against existing in vitro osteoarthritis models, which have generally cultured healthy normal chondrocytes (NCs)—in two-dimensional (2D) or 3D—with proinflammatory AMs in 2D. In this work, NCs and AMs were both encapsulated within poly(ethylene glycol) diacrylate hydrogels to mimic the native 3D environments of both cell types within the osteoarthritic joint. As with previous studies, increases in matrix metalloproteinases (MMPs) and proinflammatory cytokines associated with the early stages of osteoarthritis were observed during NC-AM coculture, as were decreases in protein-level Aggrecan and collagen II. Thereafter, the coculture system was extended to osteoarthritic chondrocytes (OACs) and AMs to evaluate the potential effects of AMs on pre-existing osteoarthritic phenotypes. OACs in coculture with AMs expressed significantly higher levels of MMP-1, MMP-3, MMP-9, MMP-13, IL-1β, TNF-α, IL-6, IL-8, and IFN-γ compared to OACs in mono-culture, indicating that proinflammatory macrophages may intensify the abnormal matrix degradation and cytokine secretion already associated with OACs. Likewise, AMs cocultured with OACs expressed significantly more IL-1β and VEGF-A compared to AM mono-culture controls, suggesting that OACs may intensify abnormal macrophage activation. Finally, OACs cultured in the presence of nonactivated macrophages produced lower levels of MMP-9 and proinflammatory cytokines IL-1β, TNF-α, and IFN-γ compared to OACs in the OAC-AM system, results that are consistent with anti-inflammatory agents temporarily reducing certain OA symptoms. In summary, the 3D coculture system developed herein captures several key features of inflammatory OA and may prove useful in future screening of therapeutic agents and/or assessment of disease progression mechanisms.
Get full access to this article
View all access options for this article.
References
1.
Martel-PelletierJ., BoileauC., PelletierJ.P., and RoughleyP.J.Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol, 22, 351, 2008.
2.
HeidariB.Knee osteoarthritis prevalence, risk factors, pathogenesis and features: part I. Caspian J Intern Med, 2, 205, 2011.
3.
CooperC., DennisonE., EdwardsM., and LitwicA.Epidemiology of osteoarthritis. Medicographia, 35, 145, 2013.
4.
JordanJ.M., HelmickC.G., RennerJ.B., LutaG., DragomirA.D., WoodardJ., FangF., SchwartzT.A., AbbateL.M., CallahanL.F., KalsbeekW.D., and HochbergM.C.Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol, 34, 172, 2007.
5.
de Lange-BrokaarB.J., Ioan-FacsinayA., van OschG.J., ZuurmondA.M., SchoonesJ., ToesR.E., HuizingaT.W., and KloppenburgM.Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage, 20, 1484, 2012.
6.
BondesonJ., WainwrightS.D., LauderS., AmosN., and HughesC.E.The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther, 8, R187, 2006.
7.
PhamT.N., RahmanP., TobinY.M., KhraishiM.M., HamiltonS.F., AlderdiceC., and RichardsonV.J.Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages. J Rheumatol, 30, 2529, 2003.
8.
LiW., DuC., WangH., and ZhangC.Increased serum ADAMTS-4 in knee osteoarthritis: a potential indicator for the diagnosis of osteoarthritis in early stages. Genet Mol Res, 13, 9642, 2014.
9.
JalbaB.A., JalbaC.S., VladoiA.D., GherghinaF., StefanE., and CruceM.Alterations in expression of cartilage-specific genes for aggrecan and collagen type II in osteoarthritis. Rom J Morphol Embryol, 52, 587, 2011.
10.
LiN.G., ShiZ.H., TangY.P., WangZ.J., SongS.L., QianL.H., QianD.W., and DuanJ.A.New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. Curr Med Chem, 18, 977, 2011.
11.
BaragiV.M., BecherG., BendeleA.M., BiesingerR., BluhmH., BoerJ., DengH., DoddR., EssersM., FeuersteinT., GallagherB.M., GegeC., HochguertelM., HofmannM., JaworskiA., JinL.X., KielyA., KorniskiB., KrothH., NixD., NolteB., PiechaD., PowersT.S., RichterF., SchneiderM., SteeneckC., SucholeikiI., TaverasA., TimmermannA., Van VeldhuizenJ., WeikJ., WuX.Y., and XiaB.A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum, 60, 2008, 2009.
12.
WojdasiewiczP., PoniatowskiL.A., and SzukiewiczD.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm, 2014, 561459, 2014.
13.
JohnsonC.I., ArgyleD.J., and ClementsD.N.In vitro models for the study of osteoarthritis. Vet J, 209, 40, 2016.
14.
TakahashiA., de AndresM.C., HashimotoK., ItoiE., and OreffoR.O.Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis. Osteoarthritis Cartilage, 23, 1946, 2015.
15.
RoubilleC., Martel-PelletierJ., and PelletierJ.Osteoarthritis treatments: where do we stand at the moment. Medicographia, 35, 172, 2013.
16.
MasukoK., MurataM., YudohK., KatoT., and NakamuraH.Anti-inflammatory effects of hyaluronan in arthritis therapy: not just for viscosity. Int J Gen Med, 2, 77, 2009.
17.
EvanichJ.D., EvanichC.J., WrightM.B., and RydlewiczJ.A.Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res. 173, 2001.
18.
WangC.T., LinJ., ChangC.J., LinY.T., and HouS.M.Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am, 86-A, 538, 2004.
19.
FioravantiA., TintiL., PascarelliN.A., Di CapuaA., LambogliaA., CappelliA., BiavaM., GiordaniA., NiccoliniS., GaleazziM., and AnziniM.In vitro effects of VA441, a new selective cyclooxygenase-2 inhibitor, on human osteoarthritic chondrocytes exposed to IL-1 beta. J Pharmacol Sci, 120, 6, 2012.
20.
ZhouX.D., LiW.J., JiangL.F., BaoJ.P., TaoL.J., LiJ., and WuL.D.Tetrandrine inhibits the Wnt/beta-catenin signalling pathway and alleviates osteoarthritis: an in vitro and in vivo study. Evid Based Compl Altern Med, 2013. Article id: 809579.
21.
BondesonJ., WainwrightS., HughesC., and CatersonB.The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin Exp Rheumatol, 26, 139, 2008.
22.
FlanneryC.R., LittleC.B., CatersonB., and HughesC.E.Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes. Matrix Biol, 18, 225, 1999.
23.
ReginatoA.M., Sanz-RodriguezC., DiazA., DharmavaramR.M., and JimenezS.A.Transcriptional modulation of cartilage-specific collagen gene expression by interferon γ and tumour necrosis factor α in cultured human chondrocytes. Biochem J, 294, 761, 1993.
24.
CaronM.M., EmansP.J., CoolsenM.M., VossL., SurtelD.A., CremersA., van RhijnL.W., and WeltingT.J.Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthritis Cartilage, 20, 1170, 2012.
25.
Schulze-TanzilG.Activation and dedifferentiation of chondrocytes: implications in cartilage injury and repair. Ann Anat, 191, 325, 2009.
26.
BartneckM., HeffelsK.H., PanY., BoviM., Zwadlo-KlarwasserG., and GrollJ.Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres. Biomaterials, 33, 4136, 2012.
27.
BhattacharjeeM., Schultz-ThaterE., TrellaE., MiotS., DasS., LoparicM., RayA.R., MartinI., SpagnoliG.C., and GhoshS.The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk-based biomaterials. Biomaterials, 34, 8161, 2013.
28.
SunL., WangX., and KaplanD.L.A 3D cartilage—inflammatory cell culture system for the modeling of human osteoarthritis. Biomaterials, 32, 5581, 2011.
29.
MurabS., ChameettachalS., BhattacharjeeM., DasS., KaplanD.L., and GhoshS.Matrix-embedded cytokines to simulate osteoarthritis-like cartilage microenvironments. Tissue Eng Part A, 19, 1733, 2013.
30.
BauB., GebhardP.M., HaagJ., KnorrT., BartnikE., and AignerT.Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum, 46, 2648, 2002.
31.
BlasioliD.J., MatthewsG.L., and KaplanD.L.The degradation of chondrogenic pellets using cocultures of synovial fibroblasts and U937 cells. Biomaterials, 35, 1185, 2014.
32.
DreierR., WallaceS., FuchsS., BrucknerP., and GrasselS.Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). J Cell Sci, 114, 3813, 2001.
33.
PeckY., NgL.Y., GohJ.Y., GaoC., and WangD.A.A three-dimensionally engineered biomimetic cartilaginous tissue model for osteoarthritic drug evaluation. Mol Pharm, 11, 1997, 2014.
34.
WilliamsC.G., KimT.K., TaboasA., MalikA., MansonP., and ElisseeffJ.In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng, 9, 679, 2003.
35.
BahneyC.S., HsuC.W., YooJ.U., WestJ.L., and JohnstoneB.A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells. FASEB J, 25, 1486, 2011.
36.
NguyenQ.T., HwangY., ChenA.C., VargheseS., and SahR.L.Cartilage-like mechanical properties of poly (ethylene glycol)-diacrylate hydrogels. Biomaterials, 33, 6682, 2012.
37.
LinS., SangajN., RazafiarisonT., ZhangC., and VargheseS.Influence of physical properties of biomaterials on cellular behavior. Pharm Res, 28, 1422, 2011.
38.
Munoz-PintoD.J., Jimenez-VergaraA.C., GharatT.P., and HahnM.S.Characterization of sequential collagen-poly(ethylene glycol) diacrylate interpenetrating networks and initial assessment of their potential for vascular tissue engineering. Biomaterials, 40, 32, 2015.
39.
Munoz-PintoD.J., SamavediS., GrigoryanB., and HahnM.S.Impact of secondary reactive species on the apparent decoupling of poly(ethylene glycol) diacrylate hydrogel average mesh size and modulus. Polymer, 77, 227, 2015.
40.
GombotzW.R., GuanghuiW., HorbettT.A., and HoffmanA.S.Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res, 25, 1547, 1991.
41.
NuttelmanC.R., TripodiM.C., and AnsethK.S.Synthetic hydrogel niches that promote hMSC viability. Matrix Biol, 24, 208, 2005.
42.
BenoitD.S.W., SchwartzM.P., DurneyA.R., and AnsethK.S.Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater, 7, 816, 2008.
43.
Becerra-BayonaS., Guiza-ArguelloV., QuX., Munoz-PintoD.J., and HahnM.S.Influence of select extracellular matrix proteins on mesenchymal stem cell osteogenic commitment in three-dimensional contexts. Acta Biomater, 8, 4397, 2012.
44.
RahimS.S., KhanN., BoddupalliC.S., HasnainS.E., and MukhopadhyayS.Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor. Immunology, 114, 313, 2005.
45.
BarthK.A., WaterfieldJ.D., and BrunetteD.M.The effect of surface roughness on RAW 264.7 macrophage phenotype. J Biomed Mater Res A, 101, 2679, 2013.
46.
LynnA.D., and BryantS.J.Phenotypic changes in bone marrow-derived murine macrophages cultured on PEG-based hydrogels activated or not by lipopolysaccharide. Acta Biomater, 7, 123, 2011.
47.
WilliamsL.M., and RidleyA.J.Lipopolysaccharide induces actin reorganization and tyrosine phosphorylation of Pyk2 and paxillin in monocytes and macrophages. J Immunol, 164, 2028, 2000.
48.
BryantS.J., NuttelmanC.R., and AnsethK.S.Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro. J Biomater Sci Polym Ed, 11, 439, 2000.
49.
BryantS.J., and AnsethK.S.Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res, 59, 63, 2002.
50.
WilliamsC.G., MalikA.N., KimT.K., MansonP.N., and ElisseeffJ.H.Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. Biomaterials, 26, 1211, 2005.
51.
LivakK.J., and SchmittgenT.D.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402, 2001.
52.
SalinasC.N., and AnsethK.S.The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J Tissue Eng Regen Med, 2, 296, 2008.
53.
SalinasC.N., and AnsethK.S.The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials, 29, 2370, 2008.
54.
AtturM., Al-MussawirH.E., PatelJ., KitayA., DaveM., PalmerG., PillingerM.H., and AbramsonS.B.Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol, 181, 5082, 2008.
55.
AignerT., ZienA., GehrsitzA., GebhardP.M., and McKennaL.Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum, 44, 2777, 2001.
56.
KapoorM., Martel-PelletierJ., LajeunesseD., PelletierJ.P., and FahmiH.Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol, 7, 33, 2011.
57.
ZengG.Q., ChenA.B., LiW., SongJ.H., and GaoC.Y.High MMP-1, MMP-2, and MMP-9 protein levels in osteoarthritis. Genet Mol Res, 14, 14811, 2015.
58.
MosserD.M., and ZhangX.Activation of murine macrophages. Curr Protoc Immunol Chapter 14, Unit 14.2, 2008.
59.
DuM., RoyK.M., ZhongL.H., ShenZ., MeyersH.E., and NicholsR.C.VEGF gene expression is regulated post-transcriptionally in macrophages. FEBS J, 273, 732, 2006.
60.
Munoz-PintoD.J., Jimenez-VergaraA.C., GelvesL.M., McMahonR.E., Guiza-ArguelloV., and HahnM.S.Probing vocal fold fibroblast response to hyaluronan in 3D contexts. Biotechnol Bioeng, 104, 821, 2009.
61.
Jimenez-VergaraA.C., Munoz-PintoD.J., Becerra-BayonaS., WangB., IacobA., and HahnM.S.Influence of glycosaminoglycan identity on vocal fold fibroblast behavior. Acta Biomater, 7, 3964, 2011.
62.
SteinmetzN.J., and BryantS.J.The effects of intermittent dynamic loading on chondrogenic and osteogenic differentiation of human marrow stromal cells encapsulated in RGD-modified poly(ethylene glycol) hydrogels. Acta Biomater, 7, 3829, 2011.
63.
BenoitD.S.W., DurneyA.R., and AnsethK.S.The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. Biomaterials, 28, 66, 2007.
64.
BurdickJ.A., and AnsethK.S.Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials, 23, 4315, 2002.
65.
LiX., EllmanM., MuddasaniP., WangJ.H., Cs-SzaboG., van WijnenA.J., and ImH.J.Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum, 60, 513, 2009.
66.
LivshitsG., ZhaiG., HartD.J., KatoB.S., WangH.Z., WilliamsF.M.K., and SpectorT.D.Interleukin-6 is a significant predictor of radiographic knee osteoarthritis the Chingford Study. Arthritis Rheum, 60, 2037, 2009.
67.
VogelC., and MarcotteE.M.Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet, 13, 227, 2012.
68.
HoffP., ButtgereitF., BurmesterG.R., JakstadtM., GaberT., AndreasK., MatziolisG., PerkaC., and RohnerE.Osteoarthritis synovial fluid activates pro-inflammatory cytokines in primary human chondrocytes. Int Orthop, 37, 145, 2013.
69.
BeekhuizenM., Bastiaansen-JenniskensY.M., KoevoetW., SarisD.B., DhertW.J., CreemersL.B., and van OschG.J.Osteoarthritic synovial tissue inhibition of proteoglycan production in human osteoarthritic knee cartilage: establishment and characterization of a long-term cartilage-synovium coculture. Arthritis Rheum, 63, 1918, 2011.
70.
MaX., SunJ., PapasavvasE., RiemannH., RobertsonS., MarshallJ., BailerR.T., MooreA., DonnellyR.P., TrinchieriG., and MontanerL.J.Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J Immunol, 164, 1722, 2000.
71.
FahyN., de Vries-van MelleM.L., LehmannJ., WeiW., GrotenhuisN., FarrellE., van der KraanP.M., MurphyJ.M., Bastiaansen-JenniskensY.M., and van OschG.J.V.M.Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state. Osteoarthr Cartilage, 22, 1167, 2014.
72.
LapaneK.L., YangS.B., DribanJ.B., LiuS.H., DubeC.E., McAlindonT.E., and EatonC.B.Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis. Arthritis Rheumatol, 67, 724, 2015.
73.
ThysenS., LuytenF.P., and LoriesR.J.U.Targets, models and challenges in osteoarthritis research. Dis Models Mech, 8, 17, 2015.
74.
LorenzH., WenzW., IvancicM., SteckE., and RichterW.Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther, 7, R156, 2005.
75.
ZhangQ., JiQ., WangX., KangL., FuY., YinY., LiZ., LiuY., XuX., and WangY.SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis. Osteoarthr Cartilage, 23, 2259, 2015.
76.
FukuiN., PurpleC.R., and SandellL.J.Cell biology of osteoarthritis: the chondrocyte's response to injury. Curr Rheumatol Rep, 3, 496, 2001.
77.
MankinH.J., DorfmanH., LippiellL., and ZarinsA.Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am, 53, 523, 1971.
78.
MiosgeN., HartmannM., MaelickeC., and HerkenR.Expression of collagen type I and type II in consecutive stages of human osteoarthritis. Histochem Cell Biol, 122, 229, 2004.
79.
HeardB.J., MartinL., RattnerJ.B., FrankC.B., HartD.A., and KrawetzR.Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid. BMC Musculoskeletal Disord, 13, 126, 2012.
80.
ScanzelloC.R., UmohE., PesslerF., Diaz-TorneC., MilesT., DiCarloE., PotterH.G., MandL., MarxR., RodeoS., GoldringS.R., and CrowM.K.Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthr Cartilage, 17, 1040, 2009.
81.
SandyJ.D., ChanD.D., TrevinoR.L., WimmerM.A., and PlaasA.Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis. Osteoarthr Cartilage, 23, 1939, 2015.
82.
WannerJ.P., SubbaiahR., Skomorovska-ProkvolitY., ShishaniY., BoilardE., MohanS., GillespieR., MiyagiM., and GobezieR.Proteomic profiling and functional characterization of early and late shoulder osteoarthritis. Arthritis Res Ther, 15, R180, 2013.
83.
MurataM., YudohK., and MasukoK.The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis?. Osteoarthr Cartilage, 16, 279, 2008.
84.
LambertC., Mathy-HartertM., DubucJ.E., MontellE., VergesJ., MunautC., NoelA., and HenrotinY.Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Res Ther, 14, R58, 2012.
85.
GhoshA., Koziol-WhiteC.J., AsosinghK., ChengG., RupleL., GronebergD., FriebeA., ComhairS.A.A., StaschJ.P., PanettieriR.A., AronicaM.A., ErzurumS.C., and StuehrD.J.Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma. Proc Natl Acad Sci USA, 113, E2355, 2016.
86.
KawataM., KoinumaD., OgamiT., UmezawaK., IwataC., WatabeT., and MiyazonoK.TGF-beta-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells. J Biochem, 151, 205, 2012.
87.
LiW., ZhangQ., WangM., WuH., MaoF., ZhangB., JiR., GaoS., SunZ., ZhuW., QianH., ChenY., and XuW.Macrophages are involved in the protective role of human umbilical cord-derived stromal cells in renal ischemia-reperfusion injury. Stem Cell Res, 10, 405, 2013.
88.
LiX., and TaiH.H.Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein −1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells. PLoS One, 8, e54073, 2013.
89.
LinC.Y., LinC.J., ChenK.H., WuJ.C., HuangS.H., and WangS.M.Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett, 580, 3042, 2006.
90.
LiuC.Y., XuJ.Y., ShiX.Y., HuangW., RuanT.Y., XieP., and DingJ.L.M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest, 93, 844, 2013.
91.
LossdorferS., GotzW., and JagerA.PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells. Clin Oral Invest, 15, 941, 2011.
92.
SchroderH.C., WangX.H., WiensM., Diehl-SeifertB., KropfK., SchlossmacherU., and MullerW.E.G.Silicate modulates the cross-talk between osteoblasts (SaOS-2) and osteoclasts (RAW 264.7 Cells): inhibition of osteoclast growth and differentiation. J Cell Biochem, 113, 3197, 2012.
93.
VirgiliF., KimD., and PackerL.Procyanidins extracted from pine bark protect alpha-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite. FEBS Lett, 431, 315, 1998.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
